News · Politics & Governance

AI leaders lobby Trump health officials in government-run chat room

AI leaders lobby Trump health officials in government-run chat room

The workspace was a government-connected Slack forum created in August 2025. It gave selected technology companies and other industry groups a direct channel to officials working on AI and healthcare policy. This mattered because the discussions concerned how health apps might be regulated, reimbursed, and promoted to patients. In February, the FDA invited companies including Microsoft, Paradox, Axiom, Apple, and Google to a listening session on conversational AI. The invitation circulated through Slack rather than a public calendar or regulatory notice. At least 35 industry organizations attended, and companies were asked to explain their products and access to sensitive medical information. The workspace also connected participants with officials such as Amy Gleason and Morgan Taylor. Legal experts said it resembled a federal advisory panel, which normally operates publicly. CMS called the wider Health Technology Ecosystem an open, voluntary collaboration, but declined to answer questions about the workspace's legality.

Based on reporting by CBS News

What was the government-run Slack workspace, and how was it used to connect AI companies with federal health officials?

The workspace was a government-connected Slack forum created in August 2025. It gave selected technology companies and other industry groups a direct channel to officials working on AI and healthcare policy. This mattered because the discussions concerned how health apps might be regulated, reimbursed, and promoted to patients.

In February, the FDA invited companies including Microsoft, Paradox, Axiom, Apple, and Google to a listening session on conversational AI. The invitation circulated through Slack rather than a public calendar or regulatory notice. At least 35 industry organizations attended, and companies were asked to explain their products and access to sensitive medical information.

The workspace also connected participants with officials such as Amy Gleason and Morgan Taylor. Legal experts said it resembled a federal advisory panel, which normally operates publicly. CMS called the wider Health Technology Ecosystem an open, voluntary collaboration, but declined to answer questions about the workspace's legality.

Which technology companies, investors, and government officials took part, and what did the companies hope to influence?

The effort brought together major technology companies, financiers, elite tech figures, and Trump administration health officials. The article specifically names Microsoft, Paradox, Axiom, Apple, and Google. It also identifies Amy Gleason, Morgan Taylor, Mehmet Oz, and Robert F. Kennedy Jr. The article does not name individual investors.

The companies were asked to describe conversational AI products, including chatbots, and explain how those products access sensitive medical information. Their participation gave them a direct opportunity to share views with FDA and CMS officials. They could help shape future guidance for developing and monitoring conversational AI in healthcare.

The broader goal was a loosely regulated Health Technology Ecosystem. Companies hoped AI services could be reimbursed by Medicare, much like services from medical professionals. They also stood to gain users through the Medicare App Library, which HHS staff described as a potentially lucrative pipeline.

How large was this effort, and how many organizations and participants were involved?

The effort began in August 2025 and continued for roughly a year as officials promoted AI across healthcare. It involved a private Slack workspace, an FDA listening session, industry conferences, and a broader CMS initiative called the Health Technology Ecosystem. The activity was extensive enough to generate thousands of reviewed Slack messages, transcripts, and recordings.

At least 35 industry organizations attended the February FDA session. Those organizations included major companies such as Microsoft, Paradox, Axiom, Apple, and Google. The article also describes participation by elite technology figures, financiers, and high-level Trump administration officials, including Amy Gleason and Morgan Taylor.

The article does not state how many individual people joined the workspace or attended the session. It therefore supports a minimum organizational figure, not a complete participant count. The effort also reached millions of seniors and people with disabilities through the Medicare App Library, which promoted about two dozen commercial apps.

Why do the FDA and CMS have authority over AI health apps, medical records, and Medicare payments?

The FDA has authority because the article identifies it as the agency responsible for regulating health apps as medical devices. That makes it the federal body involved when AI products move beyond general technology and provide patient-facing health functions. Its listening session focused on conversational AI products such as chatbots.

CMS matters because it administers Medicare and is leading efforts to make health information more accessible through digital tools. CMS officials launched an initiative allowing health apps to bill Medicare for AI services, including wearable-device tracking. They also promoted a Medicare App Library for seniors and people with disabilities.

Together, these roles give the agencies influence over safety guidance, access to medical records, and whether AI services receive Medicare payment. The article does not provide a separate legal explanation for every form of records authority. It does show officials pursuing an open, interoperable healthcare system.

What could happen if Medicare begins reimbursing AI tools and promoting them through its app library?

If Medicare reimburses AI tools, companies could receive public money for services such as wearable-device tracking. That would give these products a stronger place in mainstream healthcare and could encourage more patients and providers to use them. It would also make government policy a major route for commercial growth.

The Medicare App Library illustrates the mechanism. HHS staff said it could serve as a lucrative pipeline for new users. The webpage promotes about two dozen commercial apps to millions of seniors and people with disabilities. Easier access to medical records could let those apps provide rapid health or wellness advice.

The benefits could include greater access to records and digital tools. But doctors worry that some products are not ready, their data use is poorly understood, and there may be no liability when they are wrong. Wider promotion could therefore expand both usefulness and exposure to mistakes or privacy concerns.

Why might a private chat room that helps shape government policy be required to operate publicly as a federal advisory committee?

A federal advisory panel is a group that helps government officials develop policy. Legal experts viewed the Slack workspace as similar because companies were invited to advise the FDA on future rules for conversational AI. The participants were not merely selling products; they were discussing how federal healthcare policy might develop.

The workspace operated behind the scenes. Its invitation circulated through Slack, and the FDA session did not appear on the agency's public calendar or regulatory notices. The public was not invited. Companies were asked to explain their products, monitoring practices, and access to sensitive patient information.

Because advisory panels are required to operate in public view, the private format raised legal and transparency concerns. The article does not establish that the workspace was illegal. CMS declined to answer questions about its legality and described the broader Health Technology Ecosystem as an open, voluntary collaboration.

How do AI health apps use patients’ medical records, and what makes sensitive health data and AI-generated medical advice different from ordinary wellness technology?

The proposed system would give Americans easier access to their medical records so apps could quickly provide health or wellness advice. Companies would also gain access to that information. The article presents this as a central feature of the Health Technology Ecosystem and its goal of making health information more accessible and useful.

For example, a conversational AI product might use patient information while responding to questions. Companies were asked how their products access sensitive medical data and how they develop and monitor the technology. The article does not describe a specific app's algorithm or identify exactly which records it uses.

The concern is that medical information is highly sensitive and AI advice can affect healthcare decisions. John Whyte said some tools lack enough data, their operation is poorly understood, and there is no liability when they get things wrong. The article does not define ordinary wellness technology, but it distinguishes these tools through their records access and medical role.

Key Facts:

πŸ“Œ The Slack workspace began in August 2025.

πŸ“Œ At least 35 industry organizations attended an FDA listening session.

πŸ“Œ The FDA meeting was not listed on its public calendar.

πŸ“Œ The named companies included Microsoft, Paradox, Axiom, Apple, and Google.

πŸ“Œ Morgan Taylor invited companies through the Slack workspace.

πŸ“Œ The article does not name individual investors.

πŸ“Œ The effort began in August 2025.

More on JupiteX